Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Transmedic gets Southeast Asian rights to Pharming Group's Ruconest

Executive Summary

Singapore-based medical device and therapeutics company Transmedic Pte. Ltd. has licensed rights to Pharming Group NV’s (drugs for unmet medical needs) Ruconest (recombinant human C1 inhibitor) in the Southeast Asian countries of Brunei, Indonesia, Malaysia, the Philippines, Singapore, and Thailand. The drug is approved for acute attacks of hereditary angioedema (HAE).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies